Indication
Sickle Beta Plus Thalassemia
1 clinical trial
2 products
6 drugs
Clinical trial
Pre-Transplant Immunosuppression and Related Haploidentical Hematopoietic Cell Transplantation for Patients With Severe HemoglobinopathiesStatus: Withdrawn, Estimated PCD: 2022-12-05
Drug
bortezomibProduct
BusulfanDrug
cyclophosphamideDrug
lenalidomideDrug
fludarabineDrug
Varlilumab